Ignite Creation Date:
2025-12-25 @ 3:25 AM
Ignite Modification Date:
2026-01-23 @ 5:57 PM
Study NCT ID:
NCT00617305
Status:
COMPLETED
Last Update Posted:
2012-07-30
First Post:
2008-02-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2011-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-02-06
First Submit QC Date:
None
Study First Post Date:
2008-02-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-11
Results First Submit QC Date:
None
Results First Post Date:
2012-07-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-22
Last Update Post Date:
2012-07-30
Last Update Post Date Type:
ESTIMATED